不同给药方案对绝经过渡期功能性子宫出血患者的影响  

Effect of Different Dosage Regimens on Patients with Functional Uterine Bleeding During Menopausal Transition Period

作　　者：陈茜 CHEN Qian(First-author’s address:Fengtai Hospital,First Hospital of Peking University,Beijing 100070,China)

机构地区：[1]北京大学第一医院丰台医院

出　　处：《中外医学研究》2019年第16期113-114,共2页CHINESE AND FOREIGN MEDICAL RESEARCH

摘　　要：目的:探讨对绝经过渡期功能性子宫出血患者应用不同给药方案治疗后对其临床效果的影响。方法:将2016年1月-2017年2月笔者所在医院收治的90例绝经过渡期功能性子宫出血患者作为研究对象,采用随机数字表法分为对照组(妇康片治疗)和观察组(米非司酮治疗),每组45例。对比两组患者治疗后的临床效果。结果:治疗后,观察组治疗总有效率为95.56%,显著优于对照组的66.67%,差异有统计学意义(P<0.05)。治疗后,观察组子宫内膜厚度小于对照组,差异有统计学意义(P<0.05)。结论:对于绝经过渡期功能性子宫出血患者,采用米非司酮治疗,可及时止血,有较高临床应用价值。Objective:To investigate the effect of different dosage regimens on the clinical efficacy of functional uterine bleeding patients during menopausal transition period.Method:From January 2016 to February 2017,90 patients with functional uterine bleeding during menopausal transitional period were treated in our hospital as the research object.They were divided into control group(Norlutin Tablet treatment) and observation group(Mifepristone treatment)by random number table method,45 cases in each group.The clinical efficacy of the two groups were compared after treatment.Result:After treatment,the total effective rate of the observation group was 95.56%,which was significantly better than 66.67% of the control group,and the difference was statistically significant(P<0.05).After treatment,the endometrial thickness in the observation group was less than that in the control group,the difference was statistically significant(P<0.05).Conclusion:For patients with functional uterine bleeding during menopausal transition period,Mifepristone can stop bleeding in time,which has high clinical value.

关 键 词：绝经过渡期 功能性子宫出血 米非司酮 

分 类 号：R711.52[医药卫生—妇产科学]